Choueiri, T. K., Bauer, T. M., Merchan, J. R., McDermott, D. F., Figlin, R. A., Arrowsmith, E., Michaelson, M. D., Heath, E. I., D’Souza, A., Zhao, S., Kassalow, L., Perini, R. F., Vickery, D., Tykodi, S. S. (2025). Updated results from the phase 2 LITESPARK-003 study of belzutifan plus cabozantinib in patients with advanced clear cell renal cell carcinoma (ccRCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.549